Scheme 1. Hypothetical Biogenesis of 1
Scheme 2. Synthetic Strategy
the interesting biogenesis and potential biological activity
made it an interesting target for total synthesis. Recently,
Morimoto and co-workers reported the first total synthesis
As outlined in Scheme 3, the synthesis started with (()-
2,3-oxidosqualene (6), which was easily prepared in two
steps from squalene (2) by a reported procedure. Treatment
10
11
of this compound and established its absolute configuration.
The synthesis was accomplished in 24 steps from farnesol.
In this paper, we describe a total synthesis of 1 which
requires only six steps from squalene via a biomimetic
epoxide-opening cascade reaction.
of epoxide 6 with HCl in ether gave a 1:1 mixture of
1
2
chlorohydrin 4 and its regioisomer 7 in 92% yield. The
mixture was easily separated by flash column chromatog-
raphy, and compound 7 could be converted back to epoxide
6 in 94% yield by treatment with potassium carbonate in
methanol. Asymmetric epoxidation of 4 with Shi catalyst
Our synthetic strategy was inspired by the hypothetical
biosynthethic pathway of 1, which involves a regioselective
asymmetric epoxidation of five out of six double bonds of
squalene (2) followed by a subsequent cascade cyclization
of the pentaepoxide 3 to give 1 (Scheme 1). Mimicking this
biogenesis through the chemical synthesis presents two
challenges: regioselective asymmetric pentaepoxidation of
squalene (2) and unidirectional cascade cyclization of the
pentaepoxide 3. Our approach relied on squalene-derived
chlorohydrin 4 as the key intermediate (Scheme 2). We
expected the chlorohydrin group in 4 to serve not only as a
masking group for the terminal double bond to achieve
regioselective pentaepoxidation but also as the initiating
1
3
8
(3 equiv, 60 mol % per double bond) gave pentaepoxide
5. Without purification, compound 5 was treated with
camphorsulfonic acid (CSA) in acetone to induce an epoxide-
opening cascade cyclization which afforded the pentacyclic
compound 9 in 21% overall yield from 4 after chromato-
3
a
graphic purification on silica gel column. Since racemic 4
was used, 9 was obtained as a 1:1 mixture of two diaster-
1
14
eomers as shown by the H NMR spectrum. Reduction of
this diastereomeric mixture 9 with sodium in refluxing ether
generated the terminal double bond and opened the tethered
3,4
group (3-hydroxyl group) for the epoxide-opening cascade
cyclization. Since the chlorohydrin moiety in 4 serves as a
masking group for the olefin in 1, the chirality at the
(11) (a) Ceruti, M.; Balliano, G.; Viola, F.; Cattel, L.; Gerst, N.; Schuber,
F. Eur. J. Med. Chem. 1987, 22, 199–208. (b) van Tamelen, E. E.; Curphey,
T. J. Tetrahedron Lett. 1962, 3, 121–124. (c) van Tamelen, E. E.; Sharpless,
K. B. Tetrahedron Lett. 1967, 8, 2655–2659.
3-position is of no consequence and the racemic mixture can
(12) The preparation of (S)-4 (69% ee) has been reported in two steps
with 46% yield from racemic 6; see: Raina, S.; Singh, V. K. Tetrahedron
be used.
1
995, 51, 2467–2476.
(
13) Wang, Z.-X.; Tu, Y.; Frohn, M.; Zhang, J.-R.; Shi, Y. J. Am. Chem.
(
8) (a) Morimoto, Y.; Iwai, T.; Yoshimura, T.; Kinoshita, T. Bioorg.
Soc. 1997, 119, 11224–11235.
Med. Chem. Lett. 1998, 8, 2005–2010. (b) Bellenie, B. R.; Goodman, J. M.
Tetrahedron Lett. 2001, 42, 7477–7479. (c) Tsukube, H.; Takagi, K.;
Higashiyama, T.; Iwachido, T.; Hayama, N. Inorg. Chem. 1994, 33, 2984–
(14) The 1HNMR of the diastereomeric mixture of 9 shows two sets of
two singlets of the two methyl groups attached to C-2 with 1:1 integration
ratio indicating the diastereomeric ratio is 1:1.
2
987. (d) Schultz, W. J.; Etter, M. C.; Pocius, A. V.; Smith, S. J. Am. Chem.
(15) (a) Bromidge, S. M.; Sammes, P. G.; Street, L. J. J. Chem. Soc.,
Perkin Trans. 1 1985, 1725–1730. (b) Chen, B.; Ko, R. Y. Y.; Yuen,
M. S. M.; Cheng, K.-F.; Chu, P. J. Org. Chem. 2003, 68, 4195–4205. (c)
Geng, Z.; Chen, B.; Chiu, P. Angew. Chem., Int. Ed. Engl. 2006, 45, 6197–
6201.
Soc. 1980, 102, 7981–7982. (e) Wagner, H.; Harms, K.; Koert, U.; Meder,
S.; Boheim, G. Angew. Chem., Int. Ed. Engl. 1996, 35, 2643–2646.
(
9) (a) Suzuki, T.; Suzuki, M.; Furusaki, A.; Matsumoto, T.; Kato, A.;
Imanaka, Y.; Kurosawa, E. Tetrahedron Lett. 1985, 26, 1329–1332. (b)
Morita, H.; Kishi, E.; Takeya, K.; Itokawa, H.; Iitaka, Y. Phytochemistry
(16) Suzuki, M.; Matsuo, Y.; Takeda, S.; Suzuki, T. Phytochemistry
1993, 33, 651–656.
1
993, 34, 765–771.
10) Morimoto, Y.; Okita, T.; Kambara, H. Angew. Chem., Int. Ed. 2009,
8, 2538–2541.
(
(17) Morimoto, Y.; Okita, T.; Takaishi, M.; Tanaka, T. Angew. Chem.,
Int. Ed. Engl. 2007, 46, 1132–1135.
4
Org. Lett., Vol. 12, No. 7, 2010
1513